07
Sep
2010
Posted in I - Series A, Q - 3Q10, R - ROCKY MOUNTAIN, X - Autism, X - Device (Diagnostic), XX - UT
Lineagen (Salt Lake City, UT) a development stage content-based biomarker discovery company focused on diagnostic tests for autism, multiple sclerosis and COPD, closed a $5M Series A, bringing the total round to $10.8M. Participants include PrairieGold Venture Partners, vSpring Capital, Sanderling Ventures and Mesa Verde Venture Partners.
12
Oct
2009
Posted in I - Series B, Q - 3Q09, R - ROCKY MOUNTAIN, X - Device (Cardiology), XX - UT
Coherex Medical (Salt Lake City, UT) a development-stage medical device company focused on the Flatstent™ EF PFO Closure System used to close patent foramen ovale heart defects, closed a $16.5M Series B financing. Participants include Oxford Bioscience Partners, vSpring Capital and Tullis Health Investors.
07
Jul
2009
27
May
2009